MARKET

ABMD

ABMD

Abiomed
NASDAQ

Real-time Quotes | Nasdaq Last Sale

344.99
-2.39
-0.69%
After Hours: 354.88 +9.89 +2.87% 17:15 09/21 EDT
OPEN
349.56
PREV CLOSE
347.38
HIGH
353.46
LOW
343.66
VOLUME
285.79K
TURNOVER
--
52 WEEK HIGH
387.40
52 WEEK LOW
242.73
MARKET CAP
15.66B
P/E (TTM)
102.26
1D
5D
1M
3M
1Y
5Y
Here's Why You Should Retain Abiomed (ABMD) Stock For Now
Investors continue to be optimistic about Abiomed (ABMD) owing to its strength in the Impella product line.
Zacks · 1d ago
Return Trends At Abiomed (NASDAQ:ABMD) Aren't Appealing
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...
Simply Wall St. · 09/13 10:30
Abiomed Inc. stock outperforms market on strong trading day
marketwatch.com · 09/03 20:33
Abiomed (ABMD) Up 6% Since Last Earnings Report: Can It Continue?
Zacks.com · 09/03 15:31
Abiomed Inc. stock underperforms Wednesday when compared to competitors
marketwatch.com · 09/01 20:33
Abiomed Inc. stock outperforms competitors on strong trading day
marketwatch.com · 08/30 20:33
Abiomed Inc. stock rises Friday, still underperforms market
marketwatch.com · 08/27 20:33
Abiomed Inc. stock rises Wednesday, still underperforms market
marketwatch.com · 08/25 20:33
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ABMD. Analyze the recent business situations of Abiomed through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 10 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ABMD stock price target is 387.33 with a high estimate of 425.00 and a low estimate of 269.00.
EPS
Institutional Holdings
Institutions: 704
Institutional Holdings: 47.78M
% Owned: 105.29%
Shares Outstanding: 45.38M
TypeInstitutionsShares
Increased
161
1.95M
New
41
823.50K
Decreased
175
1.48M
Sold Out
49
378.32K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.38%
Healthcare Equipment & Supplies
+0.22%
Key Executives
Chairman/Director/President/Chief Executive Officer
Michael Minogue
Chief Financial Officer/Vice President
Todd Trapp
Chief Operating Officer/Senior Vice President
David Weber
Vice President/General Counsel/Secretary
Marc Began
Vice President
Andrew Greenfield
Lead Director/Independent Director
Dorothy Puhy
Independent Director
Paula Johnson
Independent Director
Jeannine Rivet
Independent Director
Myron Rolle
Independent Director
Eric Rose
Independent Director
Martin Sutter
Independent Director
Paul Thomas
Independent Director
Christopher Van Gorder
No Data
About ABMD
ABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily performing the pumping function of the heart. The Company's product portfolio includes the Impella 2.5, Impella CP, Impella RP, Impella LD, Impella 5.0 and AB5000. The Company's products are used in the cardiac catheterization lab (cath lab), by interventional cardiologists, the electrophysiology lab, the hybrid lab and in the heart surgery suite by heart surgeons.

Webull offers kinds of ABIOMED, Inc. stock information, including NASDAQ:ABMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ABMD stock methods without spending real money on the virtual paper trading platform.